Yy. Fan et Rs. Chapkin, IMPORTANCE OF DIETARY GAMMA-LINOLENIC ACID IN HUMAN HEALTH AND NUTRITION, The Journal of nutrition, 128(9), 1998, pp. 1411-1414
Considerable debate remains regarding the distinct biological activiti
es of individual polyunsaturated fatty acids (PUFA). One of the most i
nteresting yet controversial dietary approaches has been the possible
prophylactic role of dietary gamma-linolenic acid (GLA) in treating va
rious chronic disease states. This strategy is based on the ability of
diet to modify cellular lipid composition and eicosanoid (cyclooxygen
ase and lipoxygenase) biosynthesis. Recent studies demonstrate that di
etary GLA increases the content of its elongase product, dihomo-gamma-
linolenic acid (DGLA), within cell membranes without concomitant chang
es in arachidonic acid (AA). Subsequently, upon stimulation, DGLA can
be converted by inflammatory cells to 15-(S)-hydroxy-8,11,13-eicosatri
enoic acid and prostaglandin E-1. This is noteworthy because these com
pounds possess both anti-inflammatory and anti-protiferative propertie
s. Although an optimal feeding regimen to maximize the potential benef
its of dietary GLA has not yet been determined, it is the purpose of t
his review to summarize the most recent research that has focused on o
bjectively and reproducibly determining the mechanism(s) by which GLA
may ameliorate health problems.